Divi’s Laboratories – Wave (C) Decline Targeting Lower ZonesWave Count
Divi’s Laboratories topped at ₹7,071.50, completing a 5-wave impulse.
From there, price declined in five clear waves into Wave (A) at ₹5,856.50.
The subsequent bounce unfolded as an abc zigzag, peaking at ₹6,314.50 — aligning perfectly with the 0.382 Fibonacci retracement of the 7,071.50–5,856.50 fall.
Wave (B) therefore looks complete, though the possibility of a triangle cannot be fully dismissed. The structure now favors a Wave (C) decline, unfolding in five waves toward lower zones.
Momentum
RSI stays weak, repeatedly failing to break above 50. This confirms lack of bullish strength and supports the bearish case.
Targets
Wave (C) is expected to stretch into the ₹5,563–₹5,100 zone, defined by the 0.618-1.00 extension and prior structural supports.
Trade Plan
Bias: Bearish until Wave (C) completes
Target zone: ₹5,563–₹5,100
Stop-loss / invalidation: Close above ₹6,350.50
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. Please do your own research (DYOR) before making any trading decisions.
DIVISLAB trade ideas
DIVISLAB - Falling Wedge pattern Breakout --> BullishEntry @6248
✅ Overall View
Current Price: ₹6248.50
RSI (Relative Strength Index): 47.62 → This indicates a neutral zone (neither overbought nor oversold).
✅ Support and Resistance Levels
Supports:
S1: ₹6010
S2: ₹6020.35
S3: ₹6162
Price is above all supports, which is positive.
Resistances:
R1: ₹6248.90 (current price is very close)
R2: ₹6275.85
R3: ₹6282.50
The stock is near its immediate resistance, so watch for a breakout above ₹6249–₹6282.
✅ Fibonacci Levels
Key levels derived from previous swing:
23.6%: ₹3754.59
38.2%: ₹4388.45
50%: ₹4900.75
61.8%: ₹5413.05
78.6%: ₹6142.42 (Price is above this level → bullish sign)
✅ Moving Averages
Short-Term:
EMA5 = ₹6141.71, SMA5 = ₹6102.50 → Price is above both → short-term trend is positive.
EMA9 = ₹6136.91, SMA9 = ₹6096.78 → Also bullish short-term.
Medium-Term:
EMA20 = ₹6237.30, SMA20 = ₹6240.43 → Price is slightly above → neutral to bullish.
Long-Term:
EMA50 = ₹6383.40, SMA50 = ₹6532.76 → Price is below → long-term still weak.
EMA200 = ₹6038.53, SMA200 = ₹6107.82 → Price is above → long-term trend is positive.
✅ Interpretation
RSI near 47 → Neutral (not overbought or oversold).
Price near immediate resistance (6248.90) → If breaks above ₹6282 with volume, bullish momentum possible.
Above major Fibonacci (78.6%) and above 200-day EMA/SMA → Long-term bullish bias.
Medium-term and short-term averages show slight strength but need a breakout above ₹6282 for strong uptrend.
Understanding Volume ImbalancesUnderstanding Volume Imbalances – The Market’s Unfinished Business
A Volume Imbalance occurs when price moves very quickly upward or downward, leaving behind price zones where little or no trading has taken place – often called No Trade Zones. These imbalances can be spotted on the daily timeframe and are similar in nature to gap ups or gap downs. They typically happen due to strong news, institutional activity, or sudden shifts in sentiment. Market behavior shows that these gaps are often “filled” within 2–3 months, as price revisits these levels to balance out trading activity. For traders, these zones act as important reference points for future support, resistance, or potential trade targets.
#VolumeImbalance #PriceAction #GapTrading #MarketStructure #TechnicalAnalysis #TrueDirections1
DIVISLAB: Flag & Pole Breakout Setup Targets New ATHsNSE: DIVISLAB | Pharmaceuticals | Large Cap | Updated: June 17, 2025
📊 Technical Structure
Pole Formation: Rally from 4,955 → 6,862 (1,907 points) on high volume
Flag Consolidation: Tight range between 6,490 (support) and 6,800 (resistance)
Key Breakout Trigger: Daily close above 6,862 (ATH)
Pattern Target: 8,769 (6,862 + 1,907 pole length)
Critical Support: 6,300 (confirmed swing low)
🎯 Price Targets & Roadmap
Immediate Target: 7,200 (2024 swing high)
Strong Resistance Zone: 7,600-7,750 (analysts ceiling)
Pattern Target: 8,769 (100% pole extension)
Confirmation Required for 8,769:
• Breakout volume >650K (20% above 20D avg)
• Pharma sector PE >42 (currently 39.2)
⚡ Trade Strategy
Scenario 1: ATH Breakout (Preferred)
Entry: Daily close above 6,862 (6,880-6,900 zone)
Targets:
• 7,200 (book 30% profits)
• 7,600 (book 50% profits)
• 8,769 (full exit)
Stop Loss: 6,700
Scenario 2: Flag Breakdown
Entry: 6,300-6,160 (50-DMA confluence)
Target: 6,800 flag retest → 7,200
Stop Loss: 6,050
Risk Management Essentials: Max 2% capital per trade
⚖️ Fundamental Drivers
Strengths:
• 15.4% ROE (vs sector 12.1%)
• 17% EPS growth (FY26E)
• FII holdings ↑2.1% YoY to 18.01%
Risks:
• High PE 79.2 (sector 39.2)
• Overbought risk above 7,600
⚠️ Critical Risks
Valuation Risk: Profit-booking likely near 7,600
Sector Risk: Pharma index seasonality (+4.91% avg June)
📉 Real-Time Levels
Current Price: ₹6,538 (-2.24% today)
Support: 6,490 (flag base) → 6,300 (swing flip)
Resistance: 6,800 (flag top) → 6,862 (ATH)
Volume Alert: Breakout requires >650K shares
✅ Conclusion
DIVISLAB offers a high-reward setup with defined risk parameters. The flag breakout above 6862 is the preferred play, backed by sector leadership and earnings growth. Always hedge with stops—overvaluation remains a concern.
📜 Disclaimer
This analysis represents my personal market view and not investment advice. Trading carries significant risk of capital loss. Past performance doesn't guarantee future results. Always:
Conduct your own due diligence
Consider your risk tolerance
Consult a SEBI-certified advisor
Verify real-time data before acting
Never risk more than you can afford to lose.
[DIVISLAB] - Potential pullback entry at the [RTS + DZ]
STOCK TREND - BULLISH
MULTI TF ANALYSIS
=================
MONTHLY - Rounding Bottom + ATH breakout with good Volume
WEEKLY - Box Consolidation near ATH
DAILY - Box Consolidation + Resistance turned Support(RTS) level breakout
TECHNICAL ANALYSIS
===================
Stock Price is trading above
RSI is above
Support Level -
Demand Zone -
FUNDAMENTAL ANALYSIS
======================
Compounded Sales Growth - 19%
Compounded Profit Growth - 37%
Stock Price CAGR - 54%
Return on Equity - 15%
TRADE DESIGN
==============
Potential pullback entry at the confluence of
ENTRY - 6323
SL - 6000
TARGET - 7257
RRR - 1:2.89
Disclaimer: This chart study is for educational purpose only. Kindly trade at your own risk.
PCR ( Put Call Ratio) Trading StrategyThe Put Call Ratio (PCR) is a market sentiment indicator calculated by dividing the total volume of put options by the total volume of call options. It's used to gauge whether traders are predominantly betting on a market decline (puts) or rise (calls). A high PCR suggests bearish sentiment, while a low PCR indicates bullish sentiment.
DIVISLAB -Inverted Head and Shoulders -DailyThanks for the clarification! Yes — the chart **does** resemble an **Inverted Head and Shoulders** pattern (a bullish reversal pattern), especially visible in the price structure before the breakout above ₹6,278.
---
### 🟢 **Inverted Head and Shoulders – Analysis (Divi's Lab)**
#### **Pattern Structure:**
* **Left Shoulder:** Formed in March.
* **Head:** Deepest low around early April.
* **Right Shoulder:** Higher low formed in late April to early May.
* **Neckline:** Breakout above the ₹6,278 level confirms the pattern.
#### **Breakout Confirmation:**
* Breakout is strong, supported by **increasing volume**.
* Target derived from neckline to head height = approx. ₹1,333.
* **Target after breakout:** ₹6,278 + ₹1,333 = **₹7,611** (already marked on the chart).
---
DIVI S LABORATORIES LTDDIVI S LABORATORIES LTD
DIVISLAB: Rounding Bottom Consolidation Breakout..!!
DIVISLAB is showing good consolidation Breakout above the Rounding Bottom
structure breakout..
target and sl are on the chart....
there is lot of scope in large cap stocks as the data shows..
All data is available in public domain..
CMP: 6580
TG: 7800
SL: 5840
Stock's selection based on 5 Point Analysis:
1: Idea : Breakout.
2: Support: Volume, Delivery.
3: Technical: 21/55/200-EMA, Super trend up, RS>0 RSI.
4: Fundamental: PE, PAT, Industry & peer PE and sector performance.
5: Timing: Entry Timing on Daily chart.
Disclaimer: It is my personal view as a trader and for educational purpose only. Equity market involves risk.
Please consult your financial adviser before taking any decision.
Disclosure: might be Hold
DIVISLAB - Cup Pattern Breakout with Bullish Flag Consolidation📊 DIVISLAB – Cup Pattern Breakout with Bullish Flag Consolidation
🕰️ Timeframe: 1W | 🔍 Pattern: Cup Formation + Bullish Flag | 🚀 Long-Term Breakout Potential
📈 Technical Breakdown:
DIVISLAB has formed a massive Cup pattern on the weekly timeframe and is currently consolidating inside a Bullish Flag after hitting the neckline breakout. This is a classic continuation setup following a long accumulation.
Post breakout, the price tested the upper region and is now preparing for a potential next leg toward Fibonacci extension levels.
🔑 Key Support & Resistance Levels:
🔵 Resistance / Upside Targets:
₹6,485.00 (Cup breakout top)
₹8,829.30 (Fib extension 161.8%) 🟦
🔴 Support Zones:
₹5,290.20 – Local horizontal support
₹5,035.95 – Fib 61.8% retracement (strong support)
₹4,588.30 – Fib 50%
₹4,140.70 – Fib 38.2%
₹2,691.65 – Long-term base (0% Fib)
🧭 Strategic View:
🟢 Bias: Bullish
🔁 Retest Zone: ₹5,290–₹5,035 can be re-entry zones
🎯 Target Zones: ₹6,485 followed by ₹8,829 for positional long
🛑 Invalidation: Below ₹5,000 zone
⚠️ Disclaimer: This is an educational chart setup and not trading advice. Please conduct your own research and risk management.
📣 Follow @PriceAction_Pulse for more such clean breakouts and chart pattern analysis!
🔁 Drop a comment if DIVISLAB is on your radar for the next breakout rally 📈
DIVISLAB : Rounding Bottom Consolidation Breakout..!!DIVISLAB is showing good consolidation Breakout above the Rounding Bottom structure breakout.. target and sl are on the chart....
there is lot of scope in large cap stocks as the data shows..
All data is available in public domain..
CMP : 6580
TG : 7800
SL : 5840
Stock's selection based on 5 Point Analysis:
1: Idea : Breakout.
2: Support : Volume, Delivery .
3: Technical : 21/55/200-EMA, Super trend up, RS>0 RSI.
4: Fundamental : PE, PAT, Industry & peer PE and sector performance.
5: Timing : Entry Timing on Daily chart.
Disclaimer : It is my personal view as a trader and for educational purpose only. Equity market involves risk .
Please consult your financial adviser before taking any decision.
Disclosure : might be Hold
#DIVISLAB - Stage 1 BreakOut / Keep in WL📊 Script: DIVISLAB
Key highlights: 💡⚡
📈 Stage 1 BreakOut in Daily Time Frame.
📈 Price consolidated near Resistance.
📈 BO with Volume
📈 MACD Crossover
📈 RS Line making 52WH
📈 Can go for a swing trade
BUY ONLY ABOVE 6650 DCB
⏱️ C.M.P 📑💰- 6647
🟢 Target 🎯🏆 – 14%
⚠️ Stoploss ☠️🚫 – 7%
️⚠️ Important: Market conditions are Okish, Position size 50% per Trade. Protect Capital Always
⚠️ Important: Always Exit the trade before any Event.
⚠️ Important: Always maintain your Risk:Reward Ratio as 1:2, with this RR, you only need a 33% win rate to Breakeven.
✅Like and follow to never miss a new idea!✅
Disclaimer: I am not SEBI Registered Advisor. My posts are purely for training and educational purposes.
Eat🍜 Sleep😴 TradingView📈 Repeat 🔁
Happy learning with MMT. Cheers!🥂
Devis Lab - Darvas BOX Breakout📊 Technical Analysis Summary
✅ Pattern Identified
Darvas Box Breakout:
The price has broken out of a consolidation box (marked in blue) on strong volume, which is a bullish signal.
Volume Spike:
There is a noticeable increase in volume (highlighted in the orange circle), which validates the breakout. Volume confirmation is essential in Darvas Box patterns.
🔼 Price Action
Current Price: ₹6,279.50
Breakout from consolidation zone: ~₹6,025.50 - ₹6,250 range
🎯 Targets & Stop-Loss (SL)
Level Price (₹) Description
SL 6,025.50 Stop-loss below Darvas box base
TP1 6,759.80 First target based on box height
TP2 7,583.50 Second target (extended move)
Max TP ~7,792.95 Potential resistance/exit zone
🧠 Strategy Insights
Entry Zone: Entry ideally at or just above breakout (~₹6,250–₹6,300).
Risk-Reward Ratio:
To TP1: ~1.3x
To TP2: ~3.5x
Attractive risk/reward profile if SL is strictly followed.
Trend: Clearly bullish on the weekly timeframe.
Divis BreakoutAfter a long consolidation Divis Labs has given a breakout and the best thing is that the sector is also in momentum. NSE:DIVISLAB is a very strong stock in its sector and one can look at this share not only for short term but for medium to long term as well. Follow the line as stop loss or the level around 6300 (once that has been crossed). Strong stock and good momentum.
divis lab conditional buydivis lab has recently increased its production of certain items in pipeline
today is expiry but pharma seems safe today
condition is it should hold one candle in 30 minutes above 5950, than breakout will happen
then targets will be 6020-6080-6150
call is for intra day sl will be 5890
DIVISLAB - Inverted Head and Shoulder's Pattern - LONGThis is a 1-hour chart of DIVI'S LABORATORIES LTD showing an inverted head and shoulders pattern with the following key observations:
1. Pattern Details:
The neckline is around 5830.
The breakout has already happened with good volume, confirming the pattern.
2. EMA Analysis:
10 EMA and 20 EMA are sloping upwards, indicating bullish momentum.
200 EMA is still above the price, suggesting that the broader trend is yet to confirm a full reversal.
3. RSI Analysis:
RSI is at 72.21, which is above 60, indicating strong bullish momentum but nearing the overbought zone.
4. Trade Setup:
Entry: Ideal entry was around the neckline breakout at 5830–5840. However, a retest of the neckline (if it happens) could offer another entry point.
Stop Loss (SL): Below the right shoulder low at around 5650.
Target: Measured move based on the depth of the inverted head is approximately 399.50 points, giving a target around 6178.
Summary:
Entry: 5830–5840 (on breakout or retest)
Stop Loss: 5650
Target: 6178
Risk-to-Reward Ratio: Approximately 2:1
This analysis is for educational purposes only and should not be considered as financial advice. Trading and investing in financial markets involve significant risk, and past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any trading or investment decisions. The author is not responsible for any financial losses or damages that may result from the use of this information.